A large‐scale meta‐analytic atlas of mental health problems prevalence during the Covid‐19 early pandemic

Datos Bibliográficos

ID23324752
AutoresElena Dragioti (0000-0001-9019-4125, Pain and Rehabilitation Centre, and Department of Health, Medicine and Caring Sciences Linköping University Linköping Sweden), Michael Steward (autor de correspondencia), Han Li (0000-0002-4579-9552, University of Florida College of Medicine Gainesville Florida USA), George Tsitsas (0000-0002-7608-3258, Harokopio University Athens Greece), Keum Hwa Lee (0000-0002-1511-9587, Department of Pediatrics Yonsei University College of Medicine Seoul Republic of Korea), Jiwoo Choi (Yonsei University College of Medicine Seoul Republic of Korea), Jiwon Kim (0000-0002-1896-8832, Yonsei University College of Medicine Seoul Republic of Korea), Young Jo Choi (Yonsei University College of Medicine Seoul Republic of Korea), Konstantinos Tsamakis (0000-0002-0063-8413, Institute of Psychiatry, Psychology and Neuroscience King's College London London UK), Andrés Estradé (0000-0001-6871-5932, Department of Psychology Universidad Católica Montevideo Uruguay), Agorastos Agorastos (0000-0003-4801-4957, II. Department of Psychiatry, School of Medicine, Division of Neurosciences, Faculty of Health Sciences Aristotle University of Thessaloniki Thessaloniki Greece), Davy Vancampfort (0000-0002-4592-8625, Department of Rehabilitation Sciences KU Leuven Leuven Belgium), Dimitrios Tsiptsios (0000-0002-1601-8788, Department of Neurology Democritus University of Thrace Alexandroupolis Greece), Trevor Thompson (0009-0005-0226-395X, Centre for Chronic Illness and Ageing University of Greenwich Greenwich UK), Anna Mosina (0000-0002-2134-7463, Integrated Psychiatry Winterthur Winterthur Switzerland), Georgios Vakadaris (Faculty of Medicine, School of Health Sciences Aristotle University of Thessaloniki Thessaloniki Greece), P Fusar‐poli (0000-0003-3582-6788, Early Psychosis: Interventions and Clinical‐Detection (EPIC) Lab, Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience King's College London London UK), André F Carvalho (0000-0002-2500-5671, Department of Psychiatry, Centre for Addiction and Mental Health (CAMH) University of Toronto Toronto Ontario Canada), Christoph U Correll (0000-0002-7254-5646, Department of Psychiatry, Zucker Hillside Hospital Northwell Health Glen Oaks New York USA), Young Joo Han (Hospital Medicine Center, Haeundae Paik Hospital Inje University College of Medicine Busan Republic of Korea), Seoyeon Park (0000-0001-5024-9435, Yonsei University College of Medicine Seoul Republic of Korea), Jung-Im Shin (0000-0003-2326-1820, Department of Pediatrics Yonsei University College of Medicine Seoul Republic of Korea), Marco Solmi (0000-0003-4877-7233, Department of Psychiatry University of Ottawa Ottawa Ontario Canada)
Año2022
Volumen94
Número5
Páginas1935-1949
Fecha de publicación2022-05-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaJournal of Medical Virology (JOURNAL)
Identificadores de la revistaISSN: 0146-6615 • E-ISSN: 1096-9071
EditorialWiley (PUBLISHER • GB)
DOI10.1002/jmv.27549
OpenAlexW34958144
IdiomaEN
Citas recibidas57
Referencias citadas59

The COVID‐19 pandemic and related restrictions can impact mental health. To quantify the mental health burden of COVID‐19 pandemic, we conducted a systematic review and meta‐analysis, searching World Health Organization COVID‐19/PsycInfo/PubMed databases (09/29/2020), including observational studies reporting on mental health outcomes in any population affected by COVID‐19. Primary outcomes were the prevalence of anxiety, depression, stress, sleep problems, posttraumatic symptoms. Sensitivity analyses were conducted on severe mental health problems, in high‐quality studies, and in representative samples. Subgroup analyses were conducted stratified by age, sex, country income level, and COVID‐19 infection status. One‐hundred‐seventy‐three studies from February to July 2020 were included ( n = 502,261, median sample = 948, age = 34.4 years, females = 63%). Ninety‐one percent were cross‐sectional studies, and 18.5%/57.2% were of high/moderate quality. The highest prevalence emerged for posttraumatic symptoms in COVID‐19 infected people (94%), followed by behavioral problems in those with prior mental disorders (77%), fear in healthcare workers (71%), anxiety in caregivers/family members of people with COVID‐19 (42%), general health/social contact/passive coping style in the general population (38%), depression in those with prior somatic disorders (37%), and fear in other‐than‐healthcare workers (29%). Females and people with COVID‐19 infection had higher rates of almost all outcomes; college students/young adults of anxiety, depression, sleep problems, suicidal ideation; adults of fear and posttraumatic symptoms. Anxiety, depression, and posttraumatic symptoms were more prevalent in low‐/middle‐income countries, sleep problems in high‐income countries. The COVID‐19 pandemic adversely impacts mental health in a unique manner across population subgroups. Our results inform tailored preventive strategies and interventions to mitigate current, future, and transgenerational adverse mental health of the COVID‐19 pandemic.

Antibody · Immunochemistry · Fungal Infections and Studies · Immunology · Medicine · Mycobacterium research and diagnosis